Position in ORGO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$25,515
-$320,268 QoQ
Shares Held
10,500
-92.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 134 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $156,689,854 across 37 Drug Manufacturers - Specialty & Generic names. ORGO ranks #35 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
178,605 | $30,102,086 | |
| 2 | ZTS |
Zoetis Inc.
|
200,280 | $14,392,120 | |
| 3 | VTRS |
Viatris Inc
|
849,694 | $13,493,139 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
262,336 | $10,763,646 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
424,167 | $10,438,749 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
216,865 | $10,251,208 | |
| 7 | LQDA |
Liquidia Corp
|
122,836 | $9,793,714 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
16,798 | $9,101,659 |
All Filings in ORGO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,515 | 10,500 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $345,783 | 145,900 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $881,584 | 170,190 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $323,252 | 76,600 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $699,792 | 191,200 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $993,859 | 230,060 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $760,704 | 237,720 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $352,409 | 123,220 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $337,176 | 120,420 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $336,880 | 118,620 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $171,043 | 41,820 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $234,747 | 73,820 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $350,990 | 105,720 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $836,174 | 392,570 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,337,481 | 497,205 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,535,452 | 473,905 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $2,177,480 | 446,205 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,008,988 | 526,114 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,409,835 | 585,480 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,406,071 | 590,314 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,869,637 | 593,841 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,154,092 | 502,420 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||